In this issue:
US trends in infective endocarditis
Inclisiran in high risk patients with elevated LDL cholesterol
Testosterone replacement therapy and cardiovascular outcomes
Bococizumab in high-risk patients (SPIRE-1 and SPIRE-2)
Surgical vs transcatheter aortic-valve replacement in intermediate-risk patients
Myocardial injury in patients undergoing non-cardiac surgery
FFR-guided multivessel angioplasty in STEMI patients
Effects of fenofibrate on cardiovascular disease risk in diabetics
Sacubitril/valsartan: The PARADIGMHF study
The SPRINT intensive BP-lowering regimen may save lives
Please login below to download this issue (PDF)